Phillip McCarthy

23PUBLICATIONS
121CO-AUTHORS
Medical biochemistry - proteins and peptides (incl. medical proteomics)RehabilitationInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jan 14, 2026
6-Phosphogluconate dehydrogenase promotes mitochondrial fusion and immune suppression in tumor-associated monocytic suppressor cells.

Saeed Daneshmandi, Qi Yan, Eduardo Cortes Gomez

|Sep 18, 2025
ICANS and mortality after CAR-T therapy for NHL patients can be predicted using physical function measures of falls, balance and strength deficits, and use of an assistive device.

Nisha M Nair, Theresa E Hahn, Hillary Jacobson

|Aug 04, 2025
Deciphering neutrophil dynamics in the focal lesion tumor microenvironment to overcome immunosuppression in multiple myeloma.

Joshua Rivera, Qi Yan, Saeed Daneshmandi

|May 15, 2025
Right time: stopping multiple myeloma maintenance.

Philip McCarthy, Hemn Mohammadpour

|Feb 24, 2025
Urine-free response criteria predict progression-free survival in multiple myeloma: a post hoc analysis of BMT CTN 0702.

Rahul Banerjee, Amber R Fritz, Othman S Akhtar

|Feb 12, 2025
Minimal Residual Disease-Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials.

Qian Shi, Bruno Paiva, Levi D Pederson

Pageof 4

Frequent Collaborators

9 joint publications

Hemn Mohammadpour

5 joint publications

Marcelo C Pasquini

3 joint publications

Jianmin Wang

3 joint publications

Jingxin Qiu